QM · rank #20 · 2026-10-23
SNT
GPW · PLN · $767M (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +42.86% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +217.6% |
| Profit margin Net profit margin, trailing 12 months. | +44.8% |
| Market cap (USD) Size filter: > $300M required (USD-equivalent). | $767M |
| Anchor (recent) Close on 2026-09-23 | $350.00 |
| Anchor (far) Close on 2025-09-23 | $244.99 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Synektik S.A. is the sole-source CEE and Baltic regional distributor, installer, and service provider for Intuitive Surgical's da Vinci robotic surgery systems, alongside medical IT solutions and radiopharmaceuticals.
Rationale
High ROE (218%) and 45% profit margins validate the quality-momentum signal, powered by a 52% revenue growth and expanding high-margin recurring consumable/service revenue from a 35% YoY surge in da Vinci procedure volumes.
Material risks
- 1Single-source dependency on Intuitive Surgical and long-term risk of non-renewal or unfavorable renegotiation when the exclusive distribution contract expires after December 2031.
- 2Public-sector tender timing volatility and healthcare capital budget delays, reflected in the hardware backlog declining to PLN 43.3 million at fiscal year-end.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.